News for Healthier Living

Cellular Neighborhoods Inside Tumors May Predict Which Patients with Melanoma Benefit From Combination Immunotherapy

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma tumors may help researchers better understand which patients will benefit from combination immunotherapy after standard anti-PD-1 treatment stops working -- and which may not.

April 21, 2026


April 21 2026

April 20 2026

April 19 2026

April 18 2026

April 17 2026

April 16 2026

April 15 2026

April 14 2026

April 13 2026

April 12 2026

April 11 2026

April 10 2026

April 9 2026

April 8 2026